JP2021512898A5 - - Google Patents

Info

Publication number
JP2021512898A5
JP2021512898A5 JP2020542580A JP2020542580A JP2021512898A5 JP 2021512898 A5 JP2021512898 A5 JP 2021512898A5 JP 2020542580 A JP2020542580 A JP 2020542580A JP 2020542580 A JP2020542580 A JP 2020542580A JP 2021512898 A5 JP2021512898 A5 JP 2021512898A5
Authority
JP
Japan
Prior art keywords
compound
alkyl
salt according
formula
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020542580A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021512898A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/017422 external-priority patent/WO2019157417A1/en
Publication of JP2021512898A publication Critical patent/JP2021512898A/ja
Publication of JP2021512898A5 publication Critical patent/JP2021512898A5/ja
Pending legal-status Critical Current

Links

JP2020542580A 2018-02-09 2019-02-11 複素環p2y14受容体拮抗薬 Pending JP2021512898A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862628699P 2018-02-09 2018-02-09
US62/628,699 2018-02-09
PCT/US2019/017422 WO2019157417A1 (en) 2018-02-09 2019-02-11 Heterocyclic p2y14 receptor antagonists

Publications (2)

Publication Number Publication Date
JP2021512898A JP2021512898A (ja) 2021-05-20
JP2021512898A5 true JP2021512898A5 (https=) 2022-02-24

Family

ID=65529813

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020542580A Pending JP2021512898A (ja) 2018-02-09 2019-02-11 複素環p2y14受容体拮抗薬

Country Status (7)

Country Link
US (1) US11584736B2 (https=)
EP (1) EP3749651A1 (https=)
JP (1) JP2021512898A (https=)
CN (1) CN111868036A (https=)
AU (1) AU2019218256A1 (https=)
CA (1) CA3090788A1 (https=)
WO (1) WO2019157417A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11708346B2 (en) 2019-07-23 2023-07-25 Saint Louis University Treatment and prevention of neuropathic pain with P2Y14 antagonists
CN116964034A (zh) * 2021-01-18 2023-10-27 美国卫生和人力服务部 杂环p2y14受体拮抗剂
CN116444482B (zh) * 2023-06-14 2023-09-22 中国药科大学 噻吩-2-羧酸衍生物、其制备方法及医药用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4377586A (en) * 1981-04-30 1983-03-22 The Upjohn Company Diuretic 2,6-diaryl-4-pyridine carboxylic acids
GB0507200D0 (en) * 2005-04-08 2005-05-18 Smithkline Beecham Corp Chemical compounds
CA2706632A1 (en) * 2007-12-04 2009-06-11 Merck Frosst Canada Ltd. Substituted 2-naphthoic acids as antagonists of gpr105 activity
US8580961B2 (en) * 2010-12-13 2013-11-12 National Tsing Hua University 2-phenyl-6-azolylpyridine-based ligand and group VIII transition metal complex
US9290453B2 (en) * 2010-12-23 2016-03-22 Merck Sharp & Dohme Corp. Quinolines and aza-quinolines as CRTH2 receptor modulators
DE112011105485T5 (de) 2011-08-01 2014-06-12 Mitsubishi Electric Corporation Steuervorrichtung und Steuerverfahren für eine Spritzgussmaschine
EP2774919A1 (en) 2013-03-06 2014-09-10 Pharmeste S.R.L. In Liquidazione Novel sulfonamide TRPA1 receptor antagonists
EA033686B1 (ru) * 2015-08-03 2019-11-15 Bristol Myers Squibb Co Гетероциклические соединения, применимые в качестве модуляторов tnf-альфа
US10683277B2 (en) 2015-09-25 2020-06-16 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Triazole derivatives as P2Y14 receptor antagonists
MA53943A (fr) 2015-11-20 2021-08-25 Vitae Pharmaceuticals Llc Modulateurs de ror-gamma
US11938114B2 (en) 2017-03-10 2024-03-26 Rutgers, The State University Of New Jersey Bacterial efflux pump inhibitors
CN109096177A (zh) 2018-08-31 2018-12-28 中国药科大学 3-酰胺基苯甲酸衍生物、其制备方法及医药用途

Similar Documents

Publication Publication Date Title
FI4129989T3 (fi) Dipeptidyylipeptidaasi 1:n estäjänä toimiva nitriilijohdannainen ja sen käyttö
JP2021512898A5 (https=)
JP2006151984A5 (https=)
JP2025512474A5 (https=)
JPH08510479A (ja) 眼の炎症障害を処置するための3‐ベンゾイルフェニル酢酸誘導体を含む局所的に投与可能な組成物
JP2023504415A5 (https=)
JP2010540508A5 (https=)
JP2007502804A5 (https=)
JP2010540525A5 (https=)
JP2009523841A5 (https=)
JP2007530694A5 (https=)
JP2012522759A5 (https=)
RU2007121219A (ru) Диазациклоалканы как агонисты окситоцина
JP2011517697A5 (https=)
JP2016514141A5 (https=)
JP2007522162A5 (https=)
CA2547347A1 (en) Diazaindole-dicarbonyl-piperazinyl antiviral agents
RU2006124856A (ru) Гидронопольные производные в качестве агонистов по отношению к orl1 рецепторам человека
RU2010116293A (ru) Алкилтиопиримидины в качестве антагонистов crth2
JP2024540030A (ja) 修飾インドール化合物
JP2008531585A5 (https=)
JP3131693B2 (ja) 眼疾患を処置するための5―メチル―イソオキサゾール―4―カルボン酸アニリド類または2―ヒドロキシエチリデン―シアノ酢酸アニリド類含有医薬組成物
RU2019128534A (ru) Химические соединения для лечения туберкулеза
JP2006512321A5 (https=)
CA2589744A1 (en) Pyrrolinidium derivatives as m3 muscarinic receptors